Comments

Abeona Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Abeona Therapeutics (ABEO) operate in?

Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ABEONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q1 2025 Earnings were released on Thu May 15th, before the market open

Abeona Therapeutics (ABEO) Forecast

News Earnings Abeona Therapeutics (ABEO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Abeona Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ABEO | Benzinga

Explore Abeona Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ABEO.

Open	$6.18
Close	-
Volume / Avg.	370.15K / 1.47M
Day Range	$6.15 - $6.29
52 Wk Range	3.93 - 7.32
Market Cap	$304.31M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	11.78%
Days to Cover	1.27

Recent News

Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Disease

Abeona's Zevaskyn secures timely FDA nod, priced at $3.1 million, with 2025 sales now forecast at $31.6 million and peak U.S. revenue projected at $600 million.

Vandana Singh

Abeona Stock Surges to 52-Week High: What's Behind The Move?

Abeona shares are trading higher on Wednesday on possible continued strength after the FDA announced approval for its gene therapy.

Dylan Berman

Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy

FDA approves Zevaskyn as the first cell-based gene therapy for RDEB wounds after strong results in pivotal and long-term studies.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$6.18
Close	-
Volume / Avg.	370.15K / 1.47M
Day Range	$6.15 - $6.29
52 Wk Range	3.93 - 7.32
Market Cap	$304.31M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	11.78%
Days to Cover	1.27

About Abeona Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on develo...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Abeona Therapeutics (ABEO) stock?

You can purchase shares of Abeona Therapeutics (NASDAQ:ABEO) through any online brokerage.

View our list of the best stock brokerages

Who are Abeona Therapeutics (ABEO) competitors?

Other companies in Abeona Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), CytomX Therapeutics (NASDAQ:CTMX), Inozyme Pharma (NASDAQ:INZY), aTyr Pharma (NASDAQ:ATYR) and Olema Pharmaceuticals (NASDAQ:OLMA).

What is the forecast, or price target, for Abeona Therapeutics (ABEO) stock?

Abeona Therapeutics has a consensus price target of $16.43.

What is the current price for Abeona Therapeutics (ABEO)?

The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $6.27 last updated May 20, 2025 at 12:29 PM EDT.

Does Abeona Therapeutics (ABEO) pay a dividend?

There are no upcoming dividends for Abeona Therapeutics.

When is Abeona Therapeutics (NASDAQ:ABEO) reporting earnings?

Abeona Therapeutics’s Q2 earnings are confirmed for Monday, August 11, 2025.

Is Abeona Therapeutics (ABEO) going to split?

There is no upcoming split for Abeona Therapeutics.

What sector and industry does Abeona Therapeutics (ABEO) operate in?

Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.